EFFECTS OF TRANSDERMAL AND ORAL OXYBUTYNIN AND ITS METABOLITES ON CYSTOMETROGRAM PARAMETERS
Neimark M. 1, Davila G. W. 1, Sanders S. 2
1. Cleveland Clinic Florida, 2. Watson Pharmaceuticals
|
|
Abstract 220
|
|
|
Non Discussion Poster
Scientific Non Discussion Poster Session 18
|
|
|